Will Roche maintain at least 6% sales growth in its October 22 nine-month update?

Question

This market will resolve YES if Roche publishes results showing that Group sales for January–September 2026 increase by at least 6% at constant exchange rates against January–September 2025. The relevant reporting event is the 2026-10-22 financial release. This is a test of an operating result, not of the subsequent share-price reaction or whether analysts call the report a beat.

The nine-month Group total controls, not Pharmaceuticals alone, Diagnostics alone, standalone Q3 or growth in Swiss

Problyx · Accepted Answer

No — the community forecast puts this at 51%.

Problyx · Answer

Yes — the community forecast puts this at 49%.